Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 127.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 137.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 22,550
  • Market Cap: £133.58m
  • RiskGrade: 82

Latest ShareCast News

Cello Health sells Pulsar business to Access Intelligence

By Michele Maatouk

Date: Wednesday 02 Oct 2019

(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.

Cello Health reports positive momentum as it works on US market

By Josh White

Date: Wednesday 18 Sep 2019

(Sharecast News) - Healthcare-focussed advisory firm Cello Health reported a 6.8% improvement in net revenue to £54.5m in its half-year results on Wednesday, with its like-for-like constant currency net revenue growth standing at 4.5%.

Cello Health buys US-based scientific consulting firm ISS

By Michele Maatouk

Date: Friday 16 Aug 2019

(Sharecast News) - Healthcare-led advisory group Cello Health has announced the acquisition of Innovative Science Solutions (ISS), a US-based scientific consulting firm, for up to $10.5m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 127.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 137.50
52 Week Low 96.00
Volume 22,550
Shares Issued 104.77m
Market Cap £133.58m
RiskGrade 82

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.44% below the market average66.44% below the market average66.44% below the market average66.44% below the market average66.44% below the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Price Trend
9.76% below the market average9.76% below the market average9.76% below the market average9.76% below the market average9.76% below the market average
5% below the sector average5% below the sector average5% below the sector average5% below the sector average5% below the sector average
Income
6.78% above the market average6.78% above the market average6.78% above the market average6.78% above the market average6.78% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Growth
32.55% below the market average32.55% below the market average32.55% below the market average32.55% below the market average32.55% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 17-Oct-2019

Time Volume / Share Price
16:20 1,718 @ 128.00p
12:42 300 @ 126.00p
12:14 1,938 @ 128.19p
11:04 7,787 @ 128.25p
10:36 8,307 @ 126.26p

Cello Health Key Personnel

CEO Mark Scott

Top of Page